FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Calvin Scott & Phentermine HCL Blue Speckled tablets Recall

Phentermine HCL Blue Speckled tablets, 37

Calvin Scott & Company, Inc. · Albuquerque, NM

Risk level
Class II
Reported by FDA
Aug 26, 2020
Recall ID
D-1532-2020
Check your lot numberHow we source this data

Summary

Calvin Scott & recalled Phentermine HCL Blue Speckled tablets starting Jul 27, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1532-2020 on Aug 26, 2020. Reason: CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches. Status: Terminated.

Why it was recalled

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Product description

Phentermine HCL Blue Speckled tablets, 37.5 mg, packaged in a) 14-count bags (NDC 10702-0025-10) and b) 28-count bags (NDC 10702-0025-10), Rx Only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: KVK-Tech., Inc Newtown, PA 18940.

Lot numbers, UPCs & expiration codes

Lot #: a) 19271, Exp. Date 10/20 b) 19206, 19209B, Exp. Date 08/20; 19229, Exp. Date 10/20; 19255, Exp. Date 09/20; 19271, Exp. Date 08/20; 19301, Exp. Date 10/20; 19327, Exp. Date 11/20; 19336, Exp. 12/20; 20012, Exp. Date 1/21; 20045, Exp. Date 2/21.

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1532-2020
Classification
Class II
Status
Terminated
Recall initiated
Jul 27, 2020
FDA report date
Aug 26, 2020
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Calvin Scott & Company, Inc.

Original FDA data

Every field from FDA enforcement report D-1532-2020, exactly as published.

Show all FDA fields
City
Albuquerque
State
NM
Status
Terminated
Country
United States
Event ID
86123
Address
209 Eubank Blvd Ne
Code information
Lot #: a) 19271, Exp. Date 10/20 b) 19206, 19209B, Exp. Date 08/20; 19229, Exp. Date 10/20; 19255, Exp. Date 09/20; 19271, Exp. Date 08/20; 19301, Exp. Date 10/20; 19327, Exp. Date 11/20; 19336, Exp. 12/20; 20012, Exp. Date 1/21; 20045, Exp. Date 2/21.
Postal code
87123-2745
Report date
Aug 26, 2020
Product type
Drugs
Recall number
D-1532-2020
Classification
Class II
Recalling firm
Calvin Scott & Company, Inc.
Termination date
Apr 11, 2024
Reason for recall
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phentermine HCL Blue Speckled tablets, 37.5 mg, packaged in a) 14-count bags (NDC 10702-0025-10) and b) 28-count bags (NDC 10702-0025-10), Rx Only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: KVK-Tech., Inc Newtown, PA 18940.
Distribution pattern
Nationwide within the United States
Recall initiation date
Jul 27, 2020
Initial firm notification
E-Mail
Center classification date
Aug 20, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1532-2020, published Aug 26, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls